State NE
Clinical Trials in Nebraska
Nebraska is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Nebraska and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 117 actively recruiting studies with Nebraska sites out of 117 registered in total. The busiest research areas in Nebraska are Breast Cancer, Prostate Cancer, Multiple Myeloma. Leading sponsors running trials in the state include University of Nebraska, National Cancer Institute (NCI), AstraZeneca. By stage, Nebraska trials break down as Phase 1 (15), Phase 2 (34), Phase 3 (39), Phase 4 (4).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Nebraska
Breast Cancer (6)Prostate Cancer (3)Multiple Myeloma (3)Asthma (3)Heart Failure (2)Non-small Cell Lung Cancer (2)Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (2)Locally Recurrent Head and Neck Squamous Cell Carcinoma (2)Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma (2)Locally Recurrent Laryngeal Squamous Cell Carcinoma (2)Locally Recurrent Oral Cavity Squamous Cell Carcinoma (2)Locally Recurrent Oropharyngeal Squamous Cell Carcinoma (2)
Frequently Asked Questions — Clinical Trials in Nebraska
How many clinical trials are currently recruiting in Nebraska?
ClinicalMetric currently tracks 117 actively recruiting clinical trials with at least one location in Nebraska. The total number of registered studies—including active but not currently enrolling trials—is 117. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Nebraska?
Nebraska hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Prostate Cancer, Multiple Myeloma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Nebraska serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Nebraska?
To join a clinical trial in Nebraska, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Nebraska maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Nebraska
NCT05232916 Phase 3
Recruiting
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (...
Condition
Breast Cancer
Enrollment
750 pts
Location
United States, Belgium, France
Sponsor
Greenwich LifeSciences, Inc.
NCT06932263 Phase 2
Recruiting
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults ...
Condition
Asthma
Enrollment
540 pts
Location
United States, Argentina, Brazil
Sponsor
AstraZeneca
NCT07296484 Phase 2
Recruiting
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Condition
Type 2 Diabetes
Enrollment
1,500 pts
Location
United States
Sponsor
Sparrow Pharmaceuticals
NCT05939414 Phase 3
Recruiting
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Obse...
Condition
Oligometastatic Prostate Cancer (OMPC)
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
NCT06072430 Phase 3
Recruiting
A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment ...
Condition
Septic Shock
Enrollment
46 pts
Location
United States
Sponsor
Vivacelle Bio
NCT06855277 Phase 3
Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With P...
Condition
Prostate Cancer
Enrollment
940 pts
Location
United States, Australia, Brazil
Sponsor
Novartis Pharmaceuticals
NCT05486572 N/A
Recruiting
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Condition
Carcinoma, Hepatocellular
Enrollment
4,700 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT06637644 N/A
Recruiting
Impella RP Flex with Smart Assist
Condition
Right Ventricular (RV) Dysfunction
Enrollment
200 pts
Location
United States
Sponsor
Abiomed Inc.
NCT06942949 N/A
Recruiting
Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Ston...
Condition
Kidney Calculi; Ureteral Calculi
Enrollment
101 pts
Location
United States
Sponsor
Avvio Medical
NCT06916806 Phase 1
Recruiting
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynam...
Condition
Systemic Lupus Erythematosus
Enrollment
72 pts
Location
United States, Canada, China
Sponsor
AstraZeneca
NCT07195734 Phase 2
Recruiting
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery...
Condition
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Enrollment
180 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06806592 Phase 3
Recruiting
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to ...
Condition
Interstitial Lung Diseases
Enrollment
400 pts
Location
United States, Australia, Austria
Sponsor
Boehringer Ingelheim
NCT04585750 Phase 1, Phase 2
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP5...
Condition
Advanced Solid Tumor
Enrollment
300 pts
Location
United States, Australia, France
Sponsor
PMV Pharmaceuticals, Inc
NCT06445062 Phase 1, Phase 2
Recruiting
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Condition
Colorectal Cancer
Enrollment
1,130 pts
Location
United States
Sponsor
Revolution Medicines, Inc.
NCT00196742 N/A
Recruiting
Fabry Disease Registry & Pregnancy Sub-registry
Condition
Fabry Disease
Enrollment
9,000 pts
Location
United States, Argentina, Australia
Sponsor
Genzyme, a Sanofi Company
NCT06592924 Phase 3
Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Ca...
Condition
Prostate Cancer (Adenocarcinoma)
Enrollment
830 pts
Location
United States, Canada, Mexico
Sponsor
Canadian Cancer Trials Group
NCT07415031 Phase 2
Recruiting
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated ...
Condition
Solid Tumors
Enrollment
170 pts
Location
United States, Australia, Belgium
Sponsor
Mirati Therapeutics Inc.
NCT07309432 Phase 3
Recruiting
Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adu...
Condition
Allergic Conjunctivitis
Enrollment
350 pts
Location
United States
Sponsor
Regeneron Pharmaceuticals
NCT07105111 Phase 4
Recruiting
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With ...
Condition
Schizophrenia
Enrollment
50 pts
Location
United States
Sponsor
Neurocrine Biosciences
NCT04852887 Phase 3
Recruiting
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, O...
Condition
Stage I Breast Cancer
Enrollment
1,670 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
NCT05438732 N/A
Recruiting
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
Condition
Age-Related Macular Degeneration
Enrollment
125 pts
Location
United States
Sponsor
VisionCare, Inc.
NCT06928116 N/A
Recruiting
Heat thErapy And mobiLity in COVID-19 Survivors
Condition
Long COVID
Enrollment
99 pts
Location
United States
Sponsor
University of Nebraska
NCT07228026 N/A
Recruiting
Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxid...
Condition
Asthma
Enrollment
160 pts
Location
United States
Sponsor
Biometry Inc
NCT05896189 N/A
Recruiting
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Surv...
Condition
Breast Cancer
Enrollment
386 pts
Location
United States, Puerto Rico
Sponsor
NRG Oncology
NCT07284758 Phase 2
Recruiting
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants ...
Condition
Multiple Myeloma
Enrollment
100 pts
Location
United States
Sponsor
C4 Therapeutics, Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology